Related Experiment Video
Updated: Nov 14, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Evolution and Outcomes of Premature Coronary Artery Disease
Cara Lea Smith1, Matthew Seigerman2, Srinath Adusumalli2,3
1Department of Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Insights
Premature coronary artery disease (PCAD) affects younger individuals often missed by current risk assessments. Effective screening and targeted interventions are crucial for this growing cardiovascular disease burden.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Premature coronary artery disease (PCAD) impacts younger demographics, frequently overlooked by standard risk stratification tools.
- PCAD constitutes a significant portion of cardiovascular disease and affects a population with stagnant mortality rates, contrasting with overall declining trends.
- Existing risk models inadequately represent PCAD, highlighting a critical gap in cardiovascular disease prevention strategies.
Purpose of the Study:
- To review the progression and outcomes associated with premature coronary artery disease (PCAD).
- To examine effective screening strategies for identifying individuals at high risk for PCAD.
- To explore opportunities for targeted interventions in PCAD prevention.
Main Methods:
- Literature review of studies on premature coronary artery disease.
- Analysis of current risk stratification guidelines and their limitations.
- Evaluation of screening tools, imaging modalities, and pharmacotherapies for PCAD.
Main Results:
- PCAD affects patients not typically identified by current risk tools.
- Mortality rates for PCAD have plateaued, despite overall declines in cardiovascular mortality.
- There is significant potential for improved screening and targeted therapies for PCAD.
Conclusions:
- Proactive screening and aggressive risk factor modification are essential for younger populations at risk of PCAD.
- Current risk calculation models need enhancement to better identify individuals susceptible to PCAD.
- Precision pharmacotherapies and adapted imaging modalities offer promising avenues for PCAD management.
Purpose Of Review:
The purpose of this review is to explore the evolution and outcomes of premature coronary artery disease (PCAD) while reviewing strategies for effective screening of those at high risk for developing this disease.
Recent Findings:
Premature coronary artery disease (PCAD) affects a population of patients not typically identified as high risk by current risk stratification guidelines or traditional risk calculation tools. Not only does PCAD represent a large proportion of overall cardiovascular disease, it also afflicts a population in which the rate of mortality from cardiovascular disease has plateaued despite an overall declining population-wide cardiovascular mortality rate. There is ample opportunity for behavioral change strategies, screening tools, adapted imaging modalities, and precision pharmacotherapies to be more precisely targeted toward those at highest risk for premature coronary artery disease. Premature coronary artery disease (PCAD) is pervasive and not frequently represented within contemporary risk calculation models. Providers should pursue proactive screening and aggressive risk factor modification and deploy appropriate preventative therapies in caring for younger populations.
More Related Videos
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
06:32Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures